This content is machine translated Research PTX3 contributes to trastuzumab-induced cardiac complications Trastuzumab, the first humanized monoclonal antibody targeting human epidermal growth factor receptor 2 (ERBB2/HER2), is currently used as first-line therapy for HER2(+) tumors. However, trastuzumab increases the risk of cardiac…
